Prevalence of Psychiatric Diagnoses in Pediatric Chiari Malformation Type 1

Maureen Lacy1, Samantha DeDios-Stern2, Sarah Fredrickson2

  • 1Department of Psychiatry and Behavioral Neuroscience, The University of Chicago, Chicago, Illinois, USAmlacy@yoda.bsd.uchicago.edu.

Pediatric Neurosurgery
|August 28, 2018
PubMed

Insights

Children with Chiari malformation type 1 (CM1) show higher rates of psychiatric diagnoses like ADHD, anxiety, and depression. Maternal pregnancy complications and premature birth significantly increase the risk for these diagnoses.

Area of Science:

  • Pediatric Neurology
  • Child Psychiatry
  • Neurodevelopmental Disorders

Background:

  • Chiari malformation type 1 (CM1) is a structural defect in the cerebellum.
  • The association between CM1 and psychiatric conditions in children requires further investigation.
  • Understanding these comorbidities is crucial for comprehensive patient care.

Purpose of the Study:

  • To determine the prevalence of psychiatric diagnoses in children with CM1.
  • To identify risk factors associated with psychiatric diagnoses in this cohort.
  • To compare psychiatric diagnosis rates in CM1 patients with general population norms.

Main Methods:

  • Cross-sectional study of 86 children (ages 6-17) diagnosed with CM1.
  • Data collection via parent questionnaires, semistructured interviews, and medical record review.
  • Statistical analysis using binary logistic regression to identify risk factors.

Main Results:

  • Elevated rates of attention deficit hyperactivity disorder (ADHD) (22.1%), anxiety (12.8%), and depression (10.5%) were observed in CM1 patients.
  • First-degree relatives also showed higher rates of psychiatric diagnoses.
  • Maternal pregnancy complications (9-fold increased risk) and premature birth significantly predicted psychiatric diagnoses.

Conclusions:

  • Children with CM1 exhibit a high prevalence of psychiatric illness.
  • Pregnancy complications are strongly associated with increased psychiatric diagnosis risk.
  • Early central nervous system (CNS) developmental disturbances may underlie these associations.

Related Concept Videos

Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
1.9K
Diagnosing Acidosis and Alkalosis01:24

Diagnosing Acidosis and Alkalosis

Diagnosing acid-base imbalances involves systematically analyzing arterial blood samples, focusing on three key measurements: pH, bicarbonate (HCO3−) concentration, and carbon dioxide partial pressure (PCO2). This analysis follows a four-step process that helps identify the imbalance's underlying cause and nature.
First, the pH level is assessed to determine whether the blood pH is normal (7.35–7.45), low (acidosis), or high (alkalosis).
Next, the PCO2  and...
1.2K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
266
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
314
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
236
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
305